The next chapter for group B meningococcal vaccines

The next chapter for group B meningococcal vaccines

The majority of invasive meningococcal disease (IMD) in the developed world is caused by capsular group B Neisseria meningitidis, however success with vaccination against organisms bearing this capsule has previously been restricted to control of geographically limited clonal outbreaks. As we enter...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Wang, N, Pollard, A
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	Taylor and Francis 2017

Παρόμοια τεκμήρια

Group B meningococcal vaccine science and policy
ανά: Drysdale, SB, κ.ά.
Έκδοση: (2015)

Group B meningococcal vaccine: Recommendations for UK use
ανά: Pollard, A, κ.ά.
Έκδοση: (2014)

Group B meningococcal vaccine: recommendations for UK use.
ανά: Pollard, A, κ.ά.
Έκδοση: (2014)

Four component meningococcal capsular Group B vaccine in preterm infants.
ανά: Sadarangani, M, κ.ά.
Έκδοση: (2017)

Meningococcal vaccines.
ανά: Rüggeberg, J, κ.ά.
Έκδοση: (2004)

Meningococcal vaccines.
ανά: Collins, C, κ.ά.
Έκδοση: (2002)

Meningococcal vaccines.
ανά: Bethell, D, κ.ά.
Έκδοση: (2002)

Serogroup B meningococcal vaccines-an unfinished story.
ανά: Sadarangani, M, κ.ά.
Έκδοση: (2010)

The capsular group B meningococcal vaccine, 4CMenB : clinical experience and potential efficacy.
ανά: Rollier, C, κ.ά.
Έκδοση: (2014)

Quadrivalent meningococcal conjugate vaccines
ανά: Pace, D, κ.ά.
Έκδοση: (2009)

Quadrivalent meningococcal conjugate vaccines.
ανά: Pace, D, κ.ά.
Έκδοση: (2009)

Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B
ανά: Rivero-Calle I, κ.ά.
Έκδοση: (2019-10-01)

Vaccines for prevention of meningococcal disease.
ανά: Pollard, A, κ.ά.
Έκδοση: (2000)

An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease
ανά: Dold, C, κ.ά.
Έκδοση: (2023)

Challenges and progress in the development of a serogroup B meningococcal vaccine.
ανά: Lewis, S, κ.ά.
Έκδοση: (2009)

Gonococcal Vaccine Development: Lessons from Group B Meningococcal Vaccines
Έκδοση: (2017-08-01)

Meningococcal meningitis presenting postinfant group B meningococcal immunisation
ανά: So, N, κ.ά.
Έκδοση: (2018)

Safety of meningococcal group B vaccination in hospitalised premature infants
ανά: Kent, A, κ.ά.
Έκδοση: (2018)

The epidemiology of meningococcal disease and the impact of vaccines.
ανά: Khatami, A, κ.ά.
Έκδοση: (2010)

Meningococcal disease and vaccination in North America.
ανά: Pollard, A, κ.ά.
Έκδοση: (2001)

Reconsideration of the use of meningococcal polysaccharide vaccine.
ανά: Granoff, D, κ.ά.
Έκδοση: (2007)

Meningococcal polysaccharide-protein conjugate vaccines.
ανά: Snape, MD, κ.ά.
Έκδοση: (2005)

Impact of meningococcal group B OMV vaccines, beyond their brief
ανά: Helen Petousis-Harris
Έκδοση: (2018-05-01)

Development of group B meningococcal vaccine: a progress review
ανά: Wei ZHAO, κ.ά.
Έκδοση: (2022-08-01)

Global epidemiology of meningococcal disease and vaccine efficacy
ανά: Pollard, A
Έκδοση: (2004)

Global epidemiology of meningococcal disease and vaccine efficacy.
ανά: Pollard, A
Έκδοση: (2004)

Emerging clinical experience with vaccines against group B meningococcal disease
ανά: Wilkins, A, κ.ά.
Έκδοση: (2017)

Vaccine prevention of meningococcal disease, coming soon?
ανά: Morley, S, κ.ά.
Έκδοση: (2001)

Vaccine prevention of meningococcal disease, coming soon?
ανά: Morley, S, κ.ά.
Έκδοση: (2001)

Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules
ανά: Sadarangani, M, κ.ά.
Έκδοση: (2017)

Enter B and W: two new meningococcal vaccine programmes launched.
ανά: Ladhani, S, κ.ά.
Έκδοση: (2016)

Enter B and W: two new meningococcal vaccine programmes launched
ανά: Ladhani, S, κ.ά.
Έκδοση: (2015)

Correlation of group C meningococcal conjugate vaccine response with B- and T-lymphocyte activity.
ανά: James B Wing, κ.ά.
Έκδοση: (2012-01-01)

Alternative vaccine administration by powder injection: Needle-free dermal delivery of the glycoconjugate meningococcal group Y vaccine
ανά: Weissmueller, N, κ.ά.
Έκδοση: (2017)

Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps
ανά: F. Marc LaForce, κ.ά.
Έκδοση: (2018-05-01)

Gene expression profiling reveals insights into infant immunological and febrile responses to group B meningococcal vaccine
ανά: O'Connor, D, κ.ά.
Έκδοση: (2020)

Meningococcal disease
ανά: Pollard, A
Έκδοση: (2018)

Gene expression profiling reveals insights into infant immunological and febrile responses to group B meningococcal vaccine
ανά: Daniel O’Connor, κ.ά.
Έκδοση: (2020-11-01)

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial.
ανά: Read, R, κ.ά.
Έκδοση: (2014)

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: An observer-blind, phase 3 randomised clinical trial
ανά: Read, R, κ.ά.
Έκδοση: (2014)